Neuraxis (NRXS) Research & Development (2022 - 2025)
Neuraxis (NRXS) reported Research & Development of $146,178 for Q4 2025, up 5.6% from $138,426 a year earlier and up 11.7% from the prior quarter.
Powered by 
Analysis
Neuraxis (NRXS) Research & Development (2022 - 2025) Analysis & Trends
For FY2025, Neuraxis posted Research & Development of $493,611, up 13.8% from FY2024.
- Research & Development has a three-year compound annual growth rate of 29.8% (FY2022 to FY2025).
- By year, Research & Development came in at $433,614 in FY2024 (+156.1%), $169,315 in FY2023 (-25.0%) and $225,610 in FY2022.
- The Q4 2025 figure ranks as the highest quarterly Research & Development in data going back to Q2 2022.
- Year over year, Research & Development has now increased in each of the last four quarters, with growth averaging 152.5% over the last seven quarters.
- The high point for year-over-year Research & Development in five years was Q1 2025 (growth of 987.2%); the low point was Q1 2024 (a decline of 66.8%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $130,850 (Q3 2025), $58,319 (Q2 2025) and $60,556 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 364.00 Mn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 892.00 Mn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 412.00 Mn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 370.60 Mn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 771.00 Mn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 434.00 Mn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 554.00 Mn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 278.90 Mn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 258.00 Mn |
| 10 | Neuraxis | 91.64 Mn | 66.90 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 146,178.00 |
| Sep 30, 2025 | 130,850.00 |
| Jun 30, 2025 | 58,319.00 |
| Mar 31, 2025 | 60,556.00 |
| Dec 31, 2024 | 138,426.00 |
| Sep 30, 2024 | 126,247.00 |
| Jun 30, 2024 | 54,312.00 |
| Mar 31, 2024 | 5,570.00 |
| Dec 31, 2023 | -2,221.00 |
| Sep 30, 2023 | 44,950.00 |
| Jun 30, 2023 | 109,789.00 |
| Mar 31, 2023 | 16,797.00 |
| Dec 31, 2022 | 81,371.00 |
| Sep 30, 2022 | 86,175.00 |
| Jun 30, 2022 | 13,665.00 |
API Access
Neuraxis Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NRXS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NRXS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NRXS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();